QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
NYSE:EVH

Evolent Health (EVH) Stock Forecast, Price & News

$26.81
-0.02 (-0.07%)
(As of 09/26/2023 ET)
Compare
Today's Range
$26.68
$27.32
50-Day Range
$25.00
$31.40
52-Week Range
$21.83
$37.98
Volume
1.55 million shs
Average Volume
1.05 million shs
Market Capitalization
$3.04 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$46.56

Evolent Health MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
73.6% Upside
$46.56 Price Target
Short Interest
Bearish
6.38% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.59mentions of Evolent Health in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$1.02 M Sold Last Quarter
Proj. Earnings Growth
190.32%
From $0.31 to $0.90 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Computer And Technology Sector

345th out of 578 stocks

Management Services Industry

4th out of 6 stocks


EVH stock logo

About Evolent Health (NYSE:EVH) Stock

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

EVH Price History

EVH Stock News Headlines

Evolent Health, Inc. (NYSE:EVH): Are Analysts Optimistic?
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
Evolent Announces Second Quarter 2023 Results
Evolent Health (EVH) Q2 2023 Earnings Call Transcript
RBC Capital Keeps Their Buy Rating on Evolent Health (EVH)
Evolent Health (EVH) Receives a Buy from RBC Capital
Analyst Ratings for Evolent Health
Evolent Health (NYSE: EVH)
See More Headlines
Receive EVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

EVH Company Calendar

Last Earnings
8/02/2023
Today
9/26/2023
Next Earnings (Estimated)
11/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Management services
Sub-Industry
N/A
Employees
5,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$46.56
High Stock Price Forecast
$59.00
Low Stock Price Forecast
$32.00
Forecasted Upside/Downside
+74.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
8 Analysts

Profitability

Net Income
$-19,160,000.00
Pretax Margin
-10.85%

Debt

Sales & Book Value

Annual Sales
$1.35 billion
Cash Flow
$1.49 per share
Book Value
$8.60 per share

Miscellaneous

Free Float
109,507,000
Market Cap
$3.03 billion
Optionable
Optionable
Beta
1.52
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Seth Barrie Blackley (Age 44)
    Co-Founder, CEO & Director
    Comp: $1.79M
  • Mr. Dan McCarthy (Age 38)
    CEO of New Century Health & Pres
    Comp: $1.29M
  • Mr. John Paul Johnson (Age 39)
    Chief Financial Officer
    Comp: $994.22k
  • Mr. Jonathan David Weinberg J.D. (Age 55)
    Chief Legal Officer, Gen. Counsel & Sec.
    Comp: $696.07k
  • Ms. Emily Rafferty (Age 40)
    Chief Operating Officer
  • Mr. Aammaad Shams (Age 39)
    Chief Accounting Officer
  • Mr. Seth R. Frank
    VP of Investor Relations
  • Ms. Jessica Somers
    Sr. VP of Corp. Devel.
  • Ms. Kali Beyah
    Chief People & Brand Officer
  • Dr. John Tam M.D.
    Chief Strategy Officer













EVH Stock - Frequently Asked Questions

Should I buy or sell Evolent Health stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EVH shares.
View EVH analyst ratings
or view top-rated stocks.

What is Evolent Health's stock price forecast for 2023?

8 analysts have issued twelve-month price objectives for Evolent Health's shares. Their EVH share price forecasts range from $32.00 to $59.00. On average, they predict the company's stock price to reach $46.56 in the next twelve months. This suggests a possible upside of 74.0% from the stock's current price.
View analysts price targets for EVH
or view top-rated stocks among Wall Street analysts.

How have EVH shares performed in 2023?

Evolent Health's stock was trading at $28.08 at the beginning of the year. Since then, EVH stock has decreased by 4.7% and is now trading at $26.76.
View the best growth stocks for 2023 here
.

When is Evolent Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our EVH earnings forecast
.

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) announced its quarterly earnings results on Wednesday, August, 2nd. The technology company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.01) by $0.07. The technology company had revenue of $469.14 million for the quarter, compared to analyst estimates of $462.51 million. Evolent Health had a positive trailing twelve-month return on equity of 8.07% and a negative net margin of 3.89%.

What ETFs hold Evolent Health's stock?
What guidance has Evolent Health issued on next quarter's earnings?

Evolent Health updated its third quarter 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $500.00 million-$520.00 million, compared to the consensus revenue estimate of $522.29 million.

What is Seth Blackley's approval rating as Evolent Health's CEO?

12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX).

When did Evolent Health IPO?

(EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.74%), Bellevue Group AG (3.05%), Granahan Investment Management LLC (2.57%), William Blair Investment Management LLC (2.37%), Eventide Asset Management LLC (2.33%) and Dimensional Fund Advisors LP (2.17%). Insiders that own company stock include Cheryl Scott, Daniel Joseph Mccarthy, Diane Holder, Frank J Williams, Frank J Williams, John Paul Johnson, Jonathan Weinberg, Mary Bridget Duffy, Seth Blackley, Simon Maisey and Steve Tutewohl.
View institutional ownership trends
.

How do I buy shares of Evolent Health?

Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $26.76.

How much money does Evolent Health make?

Evolent Health (NYSE:EVH) has a market capitalization of $3.03 billion and generates $1.35 billion in revenue each year. The technology company earns $-19,160,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis.

How many employees does Evolent Health have?

The company employs 5,100 workers across the globe.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The official website for the company is www.evolenthealth.com. The technology company can be reached via phone at (571) 389-6000, via email at investorrelations@evolenthealth.com, or via fax at 571-389-6001.

This page (NYSE:EVH) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -